• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Healthcare·VRL.BO
Share

Vasundhara Rasayans Limited Stocks

₹ 136.05Last Updated 19.10.2026

Issuer Rating

5/7
Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

₹ 4.68M

₹ 136.05
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Vasundhara Rasayans Ltd. focuses on developing and globally supplying active pharmaceutical ingredients (APIs) primarily for use in antacid medications. The company's product line is offered in several physical states, including paste, conventional powder, and a finely processed micronized powder. Its commercial reach extends across both international export and the local domestic market segments. Established on March 5, 1987, the enterprise maintains its central corporate office in Hyderabad, India.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.10.2026 20:20

The Old World on New Chips: How Nvidia Is Driving the Industrial Revolution in Europe

21.10.2026 20:13

Getty Images has filed for bankruptcy. It will become privately owned.

21.10.2026 19:00

SpaceX's strong results boosted U.S. stocks. Is the worst behind us?

21.10.2026 18:30

"The Music's Still Playing": What Wall Street Recommends Doing with Meta Shares Ahead of the Earnings Report

21.10.2026 16:57

"A Lifesaving Deal": Nvidia May Back Firmus After Its IPO Is Canceled

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026